Immuno-regulatory antibodies for the treatment of cancer.
about
Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to ExpectFractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour ResponseAcute Malaria Induces PD1+CTLA4+ Effector T Cells with Cell-Extrinsic Suppressor FunctionSmall molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cellsImmune based therapy for melanomaImproving therapeutic activity of anti-CD20 antibody therapy through immunomodulation in lymphoid malignancies.Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?Management of High-Risk Squamous Cell Carcinoma of the Skin.Antibody-targeted nanoparticles for cancer treatment.Translating antibody directed enzyme prodrug therapy (ADEPT) and prospects for combination.Rejection versus escape: the tumor MHC dilemma.Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma.Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options.Transcriptome profiling in oral cavity and esophagus tissues from (S)-N'-nitrosonornicotine-treated rats reveals candidate genes involved in human oral cavity and esophageal carcinogenesis.Targetless T cells in cancer immunotherapy.A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells.Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T CellsCross-talk between cancer-initiating cells and immune cells: considerations for combination therapiesProtein Expression in Tonsillar and Base of Tongue Cancer and in Relation to Human Papillomavirus (HPV) and Clinical Outcome.
P2860
Q26775578-4A59CC5E-CF19-459A-8793-EDF62C6EAE22Q27334088-7BED64BC-112F-469F-9080-AF27D91A9A65Q28109688-0B0F771B-553C-4DF1-94A0-F37D7C711632Q33798642-F04C660C-EA79-4224-8C1F-EBDE3035F344Q36876757-3FC5BE7B-1536-4192-9948-F08CC915E974Q38799409-D248850F-DADA-4022-ADE7-C6DBAB53C65CQ38828265-BFBA6A9C-CC70-4C1C-9079-F277CC47A752Q38855017-10EB90E6-6955-412C-B6C7-72670076C5D1Q38887307-7FB88FE2-8154-40D3-BE9E-1001C156C5A5Q38979784-E981DB24-DD27-4E23-B2E7-73BF756FC991Q39063943-B814F55D-B661-4788-8609-9AE95FF81E28Q39190801-B65A1454-7EA7-4A65-B377-B611DAD7E518Q39308337-39BDA43E-F617-4F7B-920B-D5B47086140AQ40088799-599A34F5-254A-40A4-A3CF-E95ACBFFBFA8Q40322821-EC70C693-ED03-4513-A932-F5D534EEEE87Q41000160-CEEF93F6-366F-49D7-B39E-C1DEB4E59192Q42316769-0A3E9654-A3E3-484F-AB51-E43949D34DDAQ42370340-ACD33604-494E-4DC5-BC57-E9ECC38387D4Q55036871-699A521C-E235-4D49-9171-25900DF74462
P2860
Immuno-regulatory antibodies for the treatment of cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Immuno-regulatory antibodies for the treatment of cancer.
@en
type
label
Immuno-regulatory antibodies for the treatment of cancer.
@en
prefLabel
Immuno-regulatory antibodies for the treatment of cancer.
@en
P2093
P2860
P1476
Immuno-regulatory antibodies for the treatment of cancer.
@en
P2093
Eleanor J Cheadle
Jamie Honeychurch
Simon J Dovedi
P2860
P304
P356
10.1517/14712598.2015.1036737
P407
P577
2015-04-16T00:00:00Z